Progress in small-cell lung cancer: The lowest common denominator

被引：7

作者：

Gandara, David R. ^{[1
]}

Lara, Primo N., Jr. ^{[1
,2
]}

Natale, Ronald

Belani, Chandra ^{[3
]}

机构：

[1] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA

[2] Cedars Sinai Canc Ctr, Los Angeles, CA USA

[3] Penn State Canc Ctr, Hershey, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 26期

关键词：

D O I：

10.1200/JCO.2008.17.2692

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4236 / 4238

页数：3

共 13 条

[1] Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism? [J].

Beutler, E ;

Gelbart, T ;

Demina, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8170-8174

[2] Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-0897113; Silva Study) [J].

Giaccone, G ;

Debruyne, C ;

Felip, E ;

Chapman, PB ;

Grant, SC ;

Millward, M ;

Thiberville, L ;

D'addario, G ;

Coens, C ;

Rome, LS ;

Zatloukal, P ;

Masso, O ;

Legrand, C .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6854-6864

[3] Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin [J].

Han, Ji-Youn ;

Lim, Hyeong-Seok ;

Shin, Eun Soon ;

Yoo, Yeon-Kyeong ;

Park, Yong Hoon ;

Lee, Jong-Eun ;

Jang, In-Jin ;

Lee, Doe Ho ;

Lee, Jin Soo .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2237-2244

[4] Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer [J].

Hanna, N ;

Bunn, PA ;

Langer, C ;

Einhorn, L ;

Guthrie, T ;

Beck, T ;

Ansar, R ;

Ellis, P ;

Byrne, M ;

Morrison, M ;

Hariharan, S ;

Wang, B ;

Sandler, A .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2038-2043

[5] Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:: A Randomized phase III trial [J].

Hermes, Andreas ;

Bergman, Bengt ;

Bremnes, Roy ;

Ek, Lars ;

Fluge, Sverre ;

Sederholm, Christer ;

Sundstrom, Stein ;

Thaning, Lars ;

Vilsvik, Jan ;

Aasebo, Ulf ;

Soerenson, Sverre .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4261-4267

[6] Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan [J].

Innocenti, F ;

Undevia, SD ;

Iyer, L ;

Chen, PX ;

Das, S ;

Kocherginsky, M ;

Karrison, T ;

Janisch, L ;

Ramírez, J ;

Rudin, CM ;

Vokes, EE ;

Ratain, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1382-1388

[7]

LARA P, 2007, J CLIN ONCOL S, V25, pS390

[8]

NATALE RB, 2008, J CLIN ONCOL, V26, pS400

[9] Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and leukemia group B trial 9732 [J].

Niell, HB ;

Herndon, JE ;

Miller, AA ;

Watson, DM ;

Sandler, AB ;

Kelly, K ;

Marks, RS ;

Perry, MC ;

Ansari, RH ;

Otterson, G ;

Ellerton, J ;

Vokes, EE ;

Green, MR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3752-3759

[10] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer [J].

Noda, W ;

Nishiwaki, Y ;

Kawahara, M ;

Negoro, S ;

Sugiura, T ;

Yokoyama, A ;

Fukuoka, M ;

Mori, K ;

Watanabe, K ;

Tamura, T ;

Yamamoto, S ;

Saijo, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02) :85-91

← 1 2 →